Why Xenon Pharmaceuticals stock is down today as JPM Healthcare Conference nears
Xenon Pharmaceuticals shares fell 6.5% to $41.60 Monday afternoon, underperforming biotech peers ahead of next week’s J.P. Morgan Healthcare Conference. The stock traded between $45.21 and $41.45 on volume of 787,000 shares. Cantor Fitzgerald raised its price target to $55 despite the drop. Investors await updates on late-stage epilepsy trial timelines and commercialization plans.
